TriSalus Life Sciences (TLSI) Institutional Ownership $4.87 -0.01 (-0.20%) Closing price 09/23/2025 04:00 PM EasternExtended Trading$4.89 +0.02 (+0.41%) As of 09/23/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for TriSalus Life Sciences (NASDAQ:TLSI)CurrentInstitutional OwnershipPercentage2.58%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$23.33MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$295.22K Get TLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling TriSalus Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TLSI Institutional Buying and Selling by Quarter TriSalus Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Gilder Gagnon Howe & Co. LLC1,092,975$5.96M0.1%+32.1%2.888% 8/15/2025 Bridgeway Capital Management LLC75,400$411K0.0%+16.0%0.199% 8/15/2025 Bank of America Corp DE188,906$1.03M0.0%+1.8%0.499% 8/15/2025 AWM Investment Company Inc.1,250,000$6.81M0.8%N/A3.303% 8/14/2025 Nantahala Capital Management LLC2,000,000$10.90M0.4%N/A5.286% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.8,705$47K0.0%N/A0.023% 8/13/2025 New York State Common Retirement Fund19,800$108K0.0%N/A0.052% 8/13/2025 Connective Capital Management LLC32,796$179K0.2%+12.8%0.087% 8/12/2025 JPMorgan Chase & Co.7,540$41K0.0%+35,804.8%0.020% 8/8/2025 Police & Firemen s Retirement System of New Jersey5,400$29K0.0%N/A0.014% Get the Latest News and Ratings for TLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Geode Capital Management LLC455,051$2.48M0.0%+107.4%1.203% 6/27/2025 Goldman Sachs Group Inc.33,900$187K0.0%N/A0.090% 5/16/2025Goldman Sachs Group Inc.33,900$187K0.0%N/A0.105% 5/9/2025Charles Schwab Investment Management Inc.10,000$55K0.0%N/A0.031% 2/18/2025Connecticut Wealth Management LLC22,303$112K0.0%-32.2%0.073% 2/18/2025Connective Capital Management LLC27,989$140K0.2%N/A0.092% 2/17/2025Millennium Management LLC80,538$403K0.0%-17.7%0.264% 2/17/2025Bridgeway Capital Management LLC65,000$326K0.0%+333.3%0.213% 2/17/2025Bank of America Corp DE178,446$894K0.0%+120,471.6%0.585% 2/17/2025Angelo Gordon & CO. L.P.10,854$54K0.0%-48.0%0.036% 2/14/2025Lido Advisors LLC14,024$70K0.0%-60.0%0.046% 2/14/2025Northern Trust Corp32,112$161K0.0%+22.7%0.105% 2/13/2025Renaissance Technologies LLC13,400$67K0.0%N/A0.044% 2/12/2025Geode Capital Management LLC204,137$1.02M0.0%+1.9%0.670% 11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065% 11/16/2024Geode Capital Management LLC200,427$924K0.0%+45.4%0.657% 11/15/2024Vestcor Inc23,376$108K0.0%N/A0.077% 11/15/2024MSD Partners L.P.39,999$184K0.1%N/A0.131% 11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047% 8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572% 8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790% 8/2/2024Wolverine Asset Management LLC43,480$240K0.0%N/A0.160% 5/7/2024Anson Capital Inc.24,415$238K0.3%-30.3%0.091% 5/1/2024Connecticut Wealth Management LLC44,606$435K0.0%-22.0%0.167% 4/23/2024Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037% 1/30/2024Tyche Wealth Partners LLC26,664$225K0.1%N/A0.101% 1/25/2024HC Advisors LLC101,736$860K0.5%N/A0.387% (Data available from 1/1/2016 forward) TLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLSI shares? During the previous two years, 29 institutional investors and hedge funds held shares of TriSalus Life Sciences. The most heavily invested institutionals were Nantahala Capital Management LLC ($10.90M), AWM Investment Company Inc. ($6.81M), Gilder Gagnon Howe & Co. LLC ($5.96M), Geode Capital Management LLC ($2.48M), Duquesne Family Office LLC ($2.36M), Highbridge Capital Management LLC ($1.18M), and Bank of America Corp DE ($1.03M).Learn more on TriSalus Life Sciences' institutional investors. What percentage of TriSalus Life Sciences' stock is owned by institutional investors? 2.58% of TriSalus Life Sciences' stock is owned by institutional investors. Learn more on TLSI's institutional investor holdings. Which institutional investors have been buying TriSalus Life Sciences' stock? Of the 24 institutional investors that purchased TriSalus Life Sciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($2M), AWM Investment Company Inc. ($1.25M), Geode Capital Management LLC ($301.88K), Gilder Gagnon Howe & Co. LLC ($265.62K), Highbridge Capital Management LLC ($214.55K), Bank of America Corp DE ($181.67K), and Duquesne Family Office LLC ($110.97K). How much institutional buying is happening at TriSalus Life Sciences? Institutional investors have bought a total of 4,327,461 shares in the last 24 months. This purchase volume represents approximately $23.33M in transactions. Which of TriSalus Life Sciences' major shareholders have been selling company stock? The following institutional investors have sold TriSalus Life Sciences stock in the last 24 months: Lido Advisors LLC ($21K), Millennium Management LLC ($17.35K), Connecticut Wealth Management LLC ($10.58K), and Angelo Gordon & CO. L.P. ($10K). How much institutional selling is happening at TriSalus Life Sciences? Institutional investors have sold a total of 58,926 shares in the last 24 months. This volume of shares sold represents approximately $295.22K in transactions. Related Companies iRadimed Institutional Ownership Embecta Institutional Ownership Tandem Diabetes Care Institutional Ownership AxoGen Institutional Ownership SiBone Institutional Ownership Avanos Medical Institutional Ownership ZimVie Institutional Ownership OrthoPediatrics Institutional Ownership Treace Medical Concepts Institutional Ownership Semler Scientific Institutional Ownership This page (NASDAQ:TLSI) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
